Topic: Thrombosis

Media outlets are reporting on "Post-Pandemic Stress Disorder" as a cause for sudden heart conditions in young adults, which is viewed as a way to deflect from vaccine side effects. Simultaneously, Bristol Myers Squibb and Pfizer are running heavy ad rotations for blood clot and heart disease medications. Notably, Bristol Myers Squibb recently completed a $13 billion acquisition of MyoKardia, a company specializing in heart disease treatments.

Unverified reports from flight attendants suggest that recent mass flight cancellations at Southwest and American Airlines were caused by pilot shortages related to vaccine-induced thrombosis. Concerns about blood clots at high altitudes have also been linked to the deaths of several British Airways pilots. While airlines officially cite weather and technical issues, rumors of medical grounding among vaccinated flight crews persist.

Reports circulated over the weekend regarding the deaths of four British Airways pilots shortly after receiving COVID-19 vaccinations. British Airways and Reuters quickly issued fact checks to dampen speculation of a direct link. While one pilot had been chronically ill for months, the cluster of deaths raised questions about potential risks related to altitude and blood clots.

Airlines like Delta and American are requiring personnel to be vaccinated, raising concerns about blood clotting and thrombosis at high altitudes. On Good Morning America, Dr. Jen Ashton acknowledged data supporting Vitamin D3 as an anti-inflammatory but stated there is no official recommendation for its use against COVID-19. The hosts criticize medical professionals for prioritizing vaccines over established nutritional science.

Dr. Richard Urso of the Frontline Doctors group argued that hydroxychloroquine is one of the safest drugs in existence, citing its use in treating diabetes, obesity, and cardiovascular issues. He noted its ability to lower hemoglobin A1c and inhibit metastatic colorectal cancer. Urso maintains that the medical community should move past safety concerns given the drug's 65-year history of FDA approval.